AntiXero

All Day Dry Mouth Relief

Battle Cancer Better.

AntiXero is developing a next generation therapy for dry mouth as a side effect of cancer treatment and beyond. This research is funded in part by an NIH SBIR Phase I grant through the NIDCR

Leadership Team

Joe Huber

Chief Executive Officer

Howard Ketelson, PhD.

Chief Scientific Officer

Clinical Advisors

Dr. Victor Perez

Director of Corneal Research
Bascom Palmer

Dr. Alessandro Villa

Chief of Oral Medicine and Oral Oncology
Miami Cancer Institute